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Summary
Interleukin (IL)-5 and eotaxin families regulate the development of eosino-
philic inﬂammation of asthma in a co-operative manner. The exposure to
airborne lipopolysaccharide (LPS) induces varying degrees of airﬂow
obstruction and neutrophilic airway inﬂammation. Production of IL-5 and
eotaxinsubfamilychemokineswasanalysedinresponsetoDermatophagoides
pteronyssinus allergen (D.p.) according to the presence of speciﬁc IgE to D.p.,
and investigated the mechanism underlying their LPS-mediated regulation of
these cytokines in response to the speciﬁc allergen. Peripheral blood cells
(PBCs) from asthmatics with (group 1) or without (group 2) speciﬁc IgE to
D.p. and from non-asthmatics with (group 3) or without (group 4) were
stimulated with D.p. or LPS. For LPS-mediated inhibition of IL-5 and
eotaxin-2 production, LPS-induced cytokines were added to the D.p.-
stimulated PBCs. IL-5 and eotaxin-2, but not eotaxin-1 and 3, were signiﬁ-
cantly increased by D.p.-stimulated-PBCs from group 1,while only eotaxin-2
was elevated in group 3. Eotaxin-2 production was found in monocytes and
correlated with the level of speciﬁc IgE to D.p. LPS treatment resulted in the
decrease in eotaxin-2 and IL-5 production by the D.p.-stimulated PBCs. LPS-
induced IL-10 completely inhibited D.p.-stimulated production of eotaxin-2
and IL-5. The differential responses of the eotaxin family to speciﬁc antigens
suggest that the predominant role of eotaxin-2 and LPS may attenuate eosi-
nophilic inﬂammation by inhibiting IL-5 and eotaxin-2 synthesis through
IL-10 production.
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Introduction
Allergic asthma has been regarded as an atopic disease
involving allergen exposure, allergic (IgE-mediated) sensiti-
zation with a Th2 CD4
+ lymphocyte response and subse-
quent interleukin (IL)-5-mediated eosinophilic airways
inﬂammation, resulting in enhanced bronchial reactivity
and reversible airﬂow obstruction [1]. In this process,
antigen-sensitized T helper 2 (Th2) cells play a key role in
developmentof themanifestationsthroughtheirproduction
and release of speciﬁc cytokines,such as IL-4,IL-5 and IL-13
[2]. The eotaxin subfamily, a member of CC chemokines,
also participates in the development of asthma and other
allergic disorders through the mobilization of inﬂammatory
cells bearing CCR3,especially eosinophils.The potent effects
of eotaxins on eosinophils in concert with IL-5 are explained
largely by their ability to signal through the CCR3 [3].Three
members of this family have been identiﬁed: eotaxin-1 [4],
eotaxin-2 [5] and eotaxin-3 [6],and the three eotaxins share
the same CCR3 [7,8]. While limited studies have demon-
strated their differential expression and their roles in regu-
lating the kinetics of eosinophil recruitment during allergic
inﬂammation [9–12], the eotaxins/CCR3 pathway evidently
plays a fundamental role in eosinophil recruitment in
experimental allergic asthma [10,13]. In allergen-sensitized
atopic asthmatic subjects, in vitro allergen stimulation
induces IL-5 production by peripheral blood mononuclear
cells (PBMC) [14]; however, it has not been evaluated
whether the synthesis of eotaxins depends on antigen
sensitization.
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induces varying degrees of airﬂow obstruction and neutro-
phil inﬂammation and is often associated with an exacerba-
tion of established asthma in children and adults [15,16].
However, emerging evidence suggests that exposure to
endotoxin in early life prevents the development of atopy
and, potentially, allergic asthma [17–19]. The inhibitory
effect of LPS is mediated presumably by the induction of
Th1cytokinessuchasinterferon(IFN)-ãandIL-12secretion
[18,20,21] or regulatory cytokines such as IL-10 [22].
However, the effect and mechanisms of LPS on antigen-
sensitized IL-5 and eotaxins production has not yet been
evaluated. In this study, we employed an ex vivo stimulation
of peripheral whole blood cells (PBCs) that were obtained
from four groups of asthmatics and non-asthmatics with or
without speciﬁc IgE to mite Dermatophagoides pteronyssinus
(D.p.). The production of cytokines and eotaxin subfamily
chemokines in response to the mite antigen and the mecha-
nism(s) underlying their LPS-mediated regulation were
analysed.
Methods
Subjects
The study subjects comprised four groups: asthmatics with
(group 1) or without (group 2) D.p.-speciﬁc IgE, normal
controls with (group 3) or without (group 4). The asthmat-
ics had clinical symptoms and physical characteristics
compatible with the Global Initiative for Asthma (GINA)
guidelines [23]. Asthmatics showed airway reversibility,
as documented by an inhalant bronchodilator-induced
improvement of more than 15% of forced expiratory
volume in 1 second (FEV1) and/or an airway hyper-
responsiveness (AHR) to < 10 mg methacholine/ml [24].
Allergy skin prick tests were performed using 24 commercial
inhalant allergens, which included dust mites (Dermatopha-
goides farinae and D. pteronyssinus, Bencard, West Sussex,
UK) and histamine (1 mg/ml). IgE speciﬁc to D.p. was mea-
sured using the CAP system (Pharmacia Diagnostics,
Uppsala, Sweden) and was presented as speciﬁc IgE class
(1–6) according to UniCap-speciﬁc IgE Unites (kUA/l). All
subjects gave informed consent to participate in the study,
and the protocols were approved by the local ethics com-
mittee of Soonchunhyang University Hospital.
Cell culture and cytokine/chemokine production
Peripheral blood was diluted at a 1 : 1 ratio with tissue
culture medium containing RPMI-1640, 2 mml -glutamine,
25 mM HEPES, 100 U penicillin/ml and 100 mg
streptomycin/ml (JBI, Daegu, Korea). PBCs were stimulated
with various concentrations of D.p., which was generously
gifted by Professor Hong [25], and LPS (Escherichia coli
0111:B4, L-2630) (Sigma, St. Louis, MO, USA) for different
lengths of time. The culture supernatants were harvested by
centrifugation and were stored at -20°C until assayed. The
potency of the D.p. was measured by speciﬁc IgE inhibition
test with the pooled sera of 10 asthmatics having speciﬁc IgE
(score > 4), as described previously [26]. Fifty per cent inhi-
bition was obtained by preincubation of the pooled serum
with 10 mg D.p. extract/ml. The endotoxin concentration of
the mixture containing 10 mg D.p./ml was < 0·283 EU/ml
(equivalent to 28·3 pg/ml), as determined by a limulus
amoebocyte lysate kit (Bio-Whittaker, Walkersville, MD,
USA).
Measurement of cytokine and chemokine
concentrations
Cytokine and eotaxin concentrations were determined by
enzyme-linked immunosorbent assay (ELISA), using kits
from R&D Systems (Minneapolis, MN, USA) for eotaxin-2,
and eotaxin-3 and kits from BD Biosciences (San Diego,CA,
USA) for eotaxin-1,IL-5,IFN-g,IL-12 and IL-10.The detec-
tion limits for eotaxin-1, eotaxin-2, eotaxin-3, IL-5, IFN-g,
IL-12 and IL-10 were 6·3, 15·6, 62·5, 3·9, 18·7, 31·3 and
15·6 pg/ml, respectively. All concentrations below these
limits were considered as the detection limit values above for
the statistical analysis. The inter- and intra-assay coefﬁcients
of variance were below 10%.
Immunocytochemical detection of intracellular
eotaxin-2
Peripheral blood leucocytes were isolated from the venous
blood of D.p.-speciﬁc IgE-positive asthmatics using a
Percoll gradient solution. A total of 1 ¥ 10
7 cells were cul-
tured for 72 h in the presence of autologous serum (10%
v/v) and 10 mg D.p./ml, with 3 mM monensin (Sigma,
M5273) added 6 h before the termination of culture. The
cultured cells were cytocentrifuged and ﬁxed with 1%
paraformaldehyde and 0·1% saponin. Eotaxin-2-positive
cells were identiﬁed by immunostaining with anti-human
eotaxin-2 (R&D Systems) and biotinylated goat-anti-mouse
IgG (Vector Laboratories, Burlingame, CA, USA). The
negative control was incubated with isotype-matched
antibody. The cells were then counterstained with
Wright–Giemsa.
Inhibition and blocking of cytokine production in
PBCs stimulated with D.p.
Forinhibitionstudies,variousconcentrationsof IL-10,IL-12
(R&D Systems) and IFN-g (BD Bioscience) were added to
PBCs in the presence of D.p.(10 mg/ml).For blocking,PBCs
were pretreated for 30 min with various concentrations of
mouse anti-human IL-10Ra antibody (R&D Systems) or
mouse anti-human TLR4 antibody (BD Bioscience) and
then for 72 h with D.p. (10 mg/ml) or LPS (10 ng/ml).
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(RT–PCR)
PBCs from group 1 were stimulated for 72 h with D.p.in the
presence or absence of LPS and/or various concentrations of
anti-IL-10Ra. PBMCs were then isolated from the cultured
PBCs. Total RNA was extracted and reverse-transcribed by
incubationwith200USuperScriptRT(InvitrogenLifeTech-
nologies, Grand Island, NY, USA) at 42°C for 50 min. The
resulting cDNA were placed into tubes containing speciﬁc
primer pairs for human eotaxin-2,IL-5 or glyceraldehyde-3-
phosphate-dehydrogenase (GAPDH) gene, and were ampli-
ﬁedfor30cycles(onecycle:1 minat95°C,1 minat55°Cand
1 min at 72°C). The PCR products were resolved by agarose
(1%) gel electrophoresis. The primers used were follows;
eotaxin-2 forward primer 5′-GCTCTGTGGTCATCCCCTC
TCCCTG-3′, reverse primer 5′-GCAGGTGGTTT GGTTC
CAGGATAT-3′; IL-5 forward primer 5′-GAG GATGCTTC
TGCATTTGAGTTTG-3′, reverse primer 5′-GTCAATGT
ATTTCTTTATTAAGGACAAG-3′; GAPDH forward primer
5′-GGCATTGCTCTC AATGACAA-3′, reverse primer
5′-AGGGCCTC TCT CTTGCTCTC-3′.
Statistical analysis
Data were expressed as mean  s.e.m. Statistical analysis
was carried out using the spss program (version 11·0; SPSS
Inc., Chicago, IL, USA). Differences between independent
groups or samples were compared using the non-
parametric Kruskal–Wallis H-test for continuous data. If
differences were found to be signiﬁcant, the Mann–Whitney
U-test was applied to compare differences between two
samples. The Wilcoxon signed rank test was applied for
time-dependent changes in the parameters. Spearman’s
rank correlation was calculated to assess correlations
between data.
Results
Subject details
Asthmatics (groups 1 and 2) had signiﬁcantly lower FEV1
and methacholine PC20 values than did non-asthmatics
(groups 3 and 4), while the former exhibited higher blood
eosinophil levels than the latter. Speciﬁc and total IgE were
signiﬁcantly higher in the subjects allergic to D.p. (groups 1
and 3) than in the non-allergic groups (groups 2 and 4)
(Table 1). These ﬁndings are consistent with previously
described criteria [27].
Production of cytokines and chemokines by PBCs
in response to D.p.
Throughout this study, a bulk whole blood culture system
was employed in which peripheral blood was diluted at
a 1 : 1 ratio with culture medium and used without
fractionation.To optimize IL-5 and eotaxin subfamilies pro-
duction, PBCs from group 1 (n = 7) were stimulated with
various doses of D.p.for different periods of time.Eotaxin-2
and IL-5 increased continuously until 120 h after stimula-
tion with a dose of 10 mg/ml D.p. and was elevated signiﬁ-
cantly compared with those of unstimulated PBC, whereas
eotaxin-1 was decreased. No signiﬁcant differences were
found in eotaxin-3 production.Increased IL-5 and eotaxin-2
production by PBCs for 72-h stimulation with D.p. antigen
reached a plateau at a dose of 10 mg/ml D.p and eotaxin-1
was signiﬁcantly down-regulated upon exposure of PBCs in
a dose-dependent manner to D.p. antigen (Fig. 1a).
Next,westimulatedPBCsfromsubjectsof fourgroups.To
minimize the effect derived from both different absolute and
relative numbers of leucocytes in each group and in each
individual within the group, the results were expressed as a
foldincreaseof D.p.stimulationversusD.p.non-stimulation.
PBCs were obtained from four groups (group 1, n = 20;
Table 1. Clinical proﬁles of the study subjects.
Asthma Normal control
Group 1 Group 2 Group 3 Group 4
Subject (M/F) 20 (10/10) 12 (7/5) 7 (5/2) 10 (4/6)
Age (years) 30·9  2·6 33·83  1·2 29·71  2·4 32·0  3·6
Current smoker (%) 38 33·3 32·5 30
FEV1%, predicted 81·1  2·2†‡ 97·2  4·8 101·7  4·2 107·8  6·3
Methacholine PC20 (mg/ml) 2·1  1·4†‡ 2·7  1·1§¶ > 25 > 25
Blood eosinophil (%) 5·1  0·7†‡ 6·2  1·5¶ 2·1  0·2 1·7  0·4
Skin test to D.p. (%) 100*‡ 0
££ 100** 0
Total IgE (U/ml) 571·5  127·6*‡¶ 203·9  76·4¶ 185·1  37·6** 22·8  6·2
Speciﬁc IgE, to D.p. antigen 3·7  0·2*†‡ 0  0§ 2·7  0·3** 0  0
Speciﬁc IgE is presented as speciﬁc IgE class (grades 1–6) according to Unicap-speciﬁc IgE Unites (kUA/l). Values are the means  s.e.m. P-values
were obtained using the Mann–Whitney U-test or the c
2 test. The following symbols represent signiﬁcant differences (P < 0·05) between two groups:
*between groups 1 and 2,†between groups 1 and 3,‡between groups 1 and 4,§between groups 2 and 3,¶between groups 2 and 4 and **between groups
3a n d4 .
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Fig. 1. (a) Time kinetics and dose–responses of IL-5 and eotaxin family chemokine production by D.p.-stimulated PBCs. PBCs were prepared from
g r o u p1( n = 7) and were stimulated with various concentrations of D.p. for different lengths of time. Data are expressed as the means  SEM. The
statistical analysis was carried out using the Wilcoxon signed rank test. *P < 0.05, **P < 0.01. (b) Production of IL-5 and eotaxin subfamilies by
D.p.-stimulated PBCs. PBCs were stimulated with either medium or 10 mg D.p./ml for 72 h. Groups 1, 2, 3, and 4 included 20, 12, 7, and 10
individual samples, respectively. The amounts of cytokines were expressed as a fold increase in which cytokine levels in the presence of D.p. were
divided by those in its absence. *P < 0.05, **P < 0.01 vs. cytokine levels in the absence of D.p. (c) Inhibition of D.p.-induced production of eotaxin-2
and IL-5 by LPS. PBCs from group 1 (n = 7) were treated with increasing concentrations of LPS in the presence of D.p. (10 mg/ml) for 72 h, and the
eotaxin-2 and IL-5 levels in the culture supernatants were determined. *P < 0.05, **P < 0.01 vs. D.p.-induced production of eotaxin-2 and IL-5.
Cytokine production was determined by ELISA. (d) Percoll gradient-isolated leukocytes from group 1 were stimulated with medium (panels 1, 2) or
D.p. antigen (panels 3, 4), cytospin, and either incubated with anti-human eotaxin-2 antibody (panels 1, 3) or stained with Wright-Giemsa solution
(panels 2, 4). Bar =10 mm.
LPS-induced inhibition of IL-5 and eotaxin-2 production in atopic asthmatics
443 © 2007 The Author(s)
Journal compilation © 2007 British Society for Immunology, Clinical and Experimental Immunology, 147: 440–448group 2, n = 12; group 3, n = 7; and group 4, n = 10) and
were stimulated with D.p. (10 mg/ml) for 72 h. The signiﬁ-
cantly increased production of IL-5 was observed only in
group 1, while eotaxin-2 was elevated in groups 1 and 3
(Fig. 1b). In contrast, eotaxin-1 production decreased sig-
niﬁcantly in groups 1 and 3. Eotaxin-3 was not changed in
the four groups (Fig. 1b). Eotaxin-2 production in groups 1
and 3 correlated strongly with the respective levels of speciﬁc
serum IgE to D.p. (r = 0·528, P = 0·017 for group 1 and
r = 0·810, P = 0·027 for group 3) (Fig. 2). Immunocy-
tochemical and Wright–Giemsa staining of PBCs from
group 1 showed that monocytes were the eotaxin-2-
producing cells (Fig. 1d).
Inhibitory effect of LPS on D.p.-induced eotaxin-2
and IL-5 production
As eotaxin-2 and IL-5 levels increased following stimulation
with D.p., the production of these two cytokines in response
toLPSwasexamined.PBCsfromgroup1(n = 7)werestimu-
latedwithincreasingconcentrationsofLPSinthepresenceof
D.p. (10 mg/ml). The results showed that eotaxin-2 and IL-5
production declined in a dose-dependent fashion.Eotaxin-2
was inhibited completely (P = 0·01) and IL-5 was inhibited
by 80% (P = 0·01) at 10 ng/ml LPS (Fig. 1c). To examine
whether the inhibitory effect of LPS was mediated through
Toll-like receptor 4 (TLR4), a neutralization antibody to
TLR4 was added to PBC cultures from group 1 (n = 6) in the
presence of D.p. (10 mg/ml) and LPS (10 ng/ml). Eotaxin-2
and IL-5 production were partly restored by neutralization
with anti-TLR4 in a dose-dependent manner (Fig. 3a), sug-
gestinganinhibitorymechanismviaTLR4.Toidentifywhich
factor(s) mediate the inhibitory effect of LPS on the D.p.-
induced production of eotaxin-2 and IL-5, production of
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signed rank test. *P < 0.05, **P < 0.01.
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analysed in group 1 PBCs (n = 7) stimulated with LPS alone.
Among these, IFN-g, IL-12 and IL-10 were signiﬁcantly
up-regulated upon the exposure of PBCs in a dose-
dependent manner of LPS (Fig. 3b).
LPS inhibits D.p.-induced production of IL-5 and
eotaxin-2 via IL-10 production
The three cytokines induced by LPS were examined indi-
vidually for their inhibitory effect on the production of
eotaxin-2 and IL-5 by D.p.-stimulated PBCs from group 1
(n = 8). IL-10 inhibited eotaxin-2 and IL-5 production
almost completely (Fig. 4a). In contrast, IFN-g signiﬁcantly
augmented the production of both cytokines, and IL-12 had
no effect. Anti-IL-10Ra suppressed dose-dependently the
inhibitory effect of LPS on D.p.-stimulated IL-5 production
but not eotaxin-2 production (Fig. 4b), suggesting that a
signal transmitted through the IL-10R effectively blocks IL-5
production by D.p.-primed Th2 cells, yet is not effective for
monocyte eotaxin-2 production. RT–PCR analysis showed
that the LPS-mediated inhibition as well as the restoration of
IL-5 mRNA expression by anti-IL-10Ra indeed occurred at
the transcriptional level (Fig. 4c). The neutralization of
eotaxin-2 mRNA expression by anti-IL-10Ra was not
observed, indicating that the inhibitory effects of LPS on
D.p.-induced IL-5 and eotaxin-2 production are regulated
differently.
Discussion
Weemployedanexvivostimulationof peripheralbloodcells
(PBCs) that were obtained from four groups of asthmatics
and non-asthmatics with or without speciﬁc IgE to mite D.p.
PBC contains lymphocytes,monocytes and other leucocytes.
It also contains an array of protein and non-protein factors
that may inﬂuence the availability of the antigen and LPS
used. Thus it functionally represents the in vivo milieu more
accurately than do puriﬁed peripheral blood leucocytes or
combinations thereof.
Stimulation of PBCs with D.p. resulted in characteristic
expression patterns of IL-5 and eotaxin subfamily
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Fig. 4. The inhibitory effects of IL-10 on D.p. antigen-stimulated production of eotaxin-2 and IL-5. PBCs were prepared from group 1 (n = 8). (a)
PBCs were stimulated with D.p. (10 mg/ml) for 72 h in the absence or presence of recombinant IL-10, IFN-g, or IL-12 (each 0.01–1 ng/ml). (b) PBCs
were stimulated with D.p. (10 mg/ml) and LPS (10 ng/ml) in the presence of increasing concentrations of anti-IL-10Ra (0.01–1 mg/ml) for 72 h, and
eotaxin-2 and IL-5 production was evaluated. The statistical analysis was carried out using the Wilcoxon signed rank test. *P < 0.05, **P < 0.01. (c)
PBMCs from group 1 (n = 8) and were stimulated under the indicated conditions for 72 h.
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duction in D.p.-stimulated PBCs from the speciﬁc IgE-
positive (group 1) and monocytes as a major producer of
eotaxin-2. This result indicates the strict dependence of IL-5
and eotaxin-2 production on sensitization with speciﬁc
antigens. IL-5 synthesis was observed only in PBCs from
group 1. This result is in agreement with a previous study in
whichallergen-inducedIL-5productionbyPBMCfromsen-
sitized atopic subjects with symptoms, but not subjects
without symptoms, is elevated [14].
CD23,a low-afﬁnity receptor of IgE (FcåRII),is expressed
at a much higher level in monocytes from allergic asthmatics
than in cells from normal individuals [28]. It is therefore
speculated that D.p. may form a complex with circulating
speciﬁc IgE to induce eotaxin-2 production through the
engagement of abundant CD23 on monocytes from allergic
subjects. As a result, eotaxin-2 production may be related to
the presence of speciﬁc IgE. Our data demonstrate that
eotaxin-1isdown-regulatedandeotaxin-2isup-regulatedby
D.p.,whileeotaxin-3remainsunchanged.Thismaybedueto
different cell sources of each eotaxin.While monocytes are a
major source of eotaxin-2, eotaxin-1 and 3 are produced
mainly by epithelial cells [9]. Limited studies have demon-
strated the differential expression and roles of eotaxin sub-
families in regulating the kinetics of eosinophil recruitment
duringallergicinﬂammation[11,29].However,experimental
asthma models using eotaxin 1 and/or eotaxin 2 knock-out
mice showed a dominant role of eotaxin-2 in ovalbumin
(OVA)-induced airway eosinophilia [13], in spite of a
co-operative role for eotaxin-1 and eotaxin-2 in recruitment
of eosinophils to the lung tissue. We have shown that poly-
morphisminthegeneencodingeotaxin-2,butnoteotaxin-1,
is associated with a risk of asthma [30] and correlates with
plasmaeotaxin-2levels[31].Thesedata,includingours,may
suggest a dominant role of eotaxin-2 among the eotaxin
subfamily in peripheral circulation of atopic asthma.
The effect of endotoxin exposure in asthma is still
controversial. The beneﬁcial effects of LPS are thought to be
mediated by enhanced secretion of IFN-g and IL-12 [32,33],
whereasLPSaffectsasthmaticsadverselybyenhancingestab-
lished airway inﬂammation and airway obstruction [16]. In
the present study, we showed that LPS inhibited dose-
dependently the production of IL-5 and eotaxin-2 in
response to speciﬁc antigen; thus only IL-10 almost com-
pletely inhibited antigen-induced production of IL-5 and
eotaxin-2 (Figs 1–3). The other novel ﬁnding of our study is
that blocking the functioning receptor of IL-10 (IL-10Ra)
restored the inhibitory effect of LPS only on IL-5 production
(Fig. 4). These data suggest that the effect of LPS against the
manifestation of allergic asthma is achieved by reducing
eosinophilic inﬂammation through the up-regulation of
IL-10 production. In support of this ﬁnding, IL-10 has been
shown to exhibit anti-allergic activity in sensitized mice by
preventing IL-5 release and antigen-induced CD4
+ Tl y m -
phocyte and eosinophil accumulation [22].
Systemic administration of endotoxin to healthy subjects
produced a selective induction of Th1, as conﬁrmed by
increasedIL-2productionversusdecreasedIFN-gammapro-
duction and Th2 chemokine ligands such as CCR4 receptor
[34]. These in vivo data were not in agreement with ours in
terms of different patterns of IFN-gamma production. It
would be interesting to evaluate whether IL-10 production is
elevated in a human endotoxin model, but this has not yet
been attempted. In contrast to systemic administration,
inhalation of endotoxin induced different patterns of reac-
tion in the airways. Inhalation of endotoxin has been recog-
nized as an important factor in the aetiology of occupational
lung diseases, including non-allergic asthma [35]. Eosino-
philic inﬂammation is generally considered to be the main
feature of allergic asthmatic airways and is presumed to be
crucial in the pathogenesis of allergic asthma [36]. Endot-
oxin in house dust is associated with exacerbations of pre-
existing asthma in children and adults [16,37], and induces
neutrophilic airways inﬂammation via IL-8 secretion [38].
The switching of eosinophilic inﬂammation into neutro-
philic inﬂammation in the acute exacerbation of allergic
asthma is contributed mainly by up-regulation of neutro-
philic chemokines such as IL-8. In addition, down-
regulation of IL-5 and eotaxin may be one mechanism to
reduce the eosinophilic inﬂammation in the LPS-induced
neutrophilic airway inﬂammation of asthmatics,as shown in
experimental models [39], although this has not been
revealed in the airways of asthmatics. IL-10 may exert an
inhibitory effect on eotaxin-2 production via another
pathway such as IL-10Rb [40], or an unknown pathway.
Intriguingly, IFN-g treatment enhanced the production of
IL-5 and eotaxin-2 by antigen-stimulated PBCs, while IL-12
had no effect (Fig. 4a). This observation is in line with pre-
vious ﬁndings that the suppression of airway eosinophilia
and AHR by LPS [41] or killed mycobacteria [42] is not
attributable to a Th1 shift.
In summary, two important conclusions can be drawn
from our results: ﬁrst, speciﬁc antigen-stimulated whole-
blood cultures from asthmatics and normal controls with or
without speciﬁc IgE to D.p. produce unique patterns of IL-5
and eotaxin-2. Secondly, LPS inhibits antigen-induced pro-
duction of IL-5 and eotaxin-2 via IL-10 secretion. The
inhibitory effect of endotoxin may be associated with its
abilitytoattenuateeosinophilicinﬂammationoreosinophil-
mediated immune responses.
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